Expression and potential immune involvement of cuproptosis in kidney renal clear cell carcinoma

被引:25
|
作者
Liu, Hengrui [1 ]
机构
[1] Tianjin Yinuo Biomed Co Ltd, 1 Shuchang Pk,Wanxin St, Tianjin, Peoples R China
关键词
Cuproptosis; KIRC; Genes; Immunotherapy;
D O I
10.1016/j.cancergen.2023.03.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cuproptosis is a newly identified programmed cell death pathway mediated by intracellular free copper. Cuproptosis genes were studied in this study for a better insight into the role of cuproptosis in cancers. The analysis identified kidney renal clear cell carcinoma (KIRC) as a cancer type most likely to be affected by cuproptosis. This study analyzed the multi-omic data to explore the cancer-noncancer expression pattern and potential immune involvement of the cuproptosis pathway in KIRC. This study clustered the TCGA KIRC samples based on the gene set of 12 cuproptosis genes to study the role of cuproptosis in the KIRC immune microenvironment and found the potential value of cuproptosis signature for immunotherapy prognosis. This study concluded that cuproptosis might affect KIRC and had potential application value in immune therapy. Hopefully, this study can contribute to the application of cuproptosis in the clinical therapy of KIRC.& COPY; 2023 Elsevier Inc. All rights reserved.
引用
收藏
页码:21 / 25
页数:5
相关论文
共 50 条
  • [21] Calreticulin as a prognostic biomarker and correlated with immune infiltrate in kidney renal clear cell carcinoma
    Sun, Ming
    Qi, Shanshan
    Wu, Min
    Xia, Wei
    Xiong, Hao
    FRONTIERS IN GENETICS, 2022, 13
  • [22] APOBEC3G expression correlates with unfavorable prognosis and immune infiltration in kidney renal clear cell carcinoma
    Peng, Ting
    Liu, Binghan
    Lin, Shitong
    Cao, Canhui
    Wu, Ping
    Zhi, Wenhua
    Wei, Ye
    Chu, Tian
    Gui, Lingli
    Ding, Wencheng
    HELIYON, 2022, 8 (12)
  • [23] Construction of cuproptosis signature based on bioinformatics and experimental validation in clear cell renal cell carcinoma
    Xi Tian
    Shuxuan Zhu
    Wangrui Liu
    Xinrui Wu
    Gaomeng Wei
    Ji Zhang
    Aihetaimujiang Anwaier
    Cong chen
    Shiqi Ye
    Xiangxian Che
    Wenhao Xu
    Yuanyuan Qu
    Hailiang Zhang
    Dingwei Ye
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 17451 - 17466
  • [24] Prognosis, Immune Microenvironment Infiltration and Immunotherapy Response in Clear Cell Renal Cell Carcinoma Based on Cuproptosis-related Immune Checkpoint Gene Signature
    Liu, Gang
    Li, Feifei
    Ge, Yuntian
    Shi, Yaxing
    Ren, Fang
    Zhu, Liancheng
    JOURNAL OF CANCER, 2023, 14 (17): : 3335 - 3350
  • [25] Construction of cuproptosis signature based on bioinformatics and experimental validation in clear cell renal cell carcinoma
    Tian, Xi
    Zhu, Shuxuan
    Liu, Wangrui
    Wu, Xinrui
    Wei, Gaomeng
    Zhang, Ji
    Anwaier, Aihetaimujiang
    Chen, Cong
    Ye, Shiqi
    Che, Xiangxian
    Xu, Wenhao
    Qu, Yuanyuan
    Zhang, Hailiang
    Ye, Dingwei
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (19) : 17451 - 17466
  • [26] The cuproptosis-associated 13 gene signature as a robust predictor for outcome and response to immune- and targeted-therapies in clear cell renal cell carcinoma
    Yuan, Huiyang
    Qin, Xin
    Wang, Jing
    Yang, Qingya
    Fan, Yidong
    Xu, Dawei
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [27] A Cuproptosis-Related Gene Model For Predicting the Prognosis of Clear Cell Renal Cell Carcinoma
    Mei, Wangli
    Liu, Xiang
    Jia, Xuyang
    Jin, Liang
    Xin, Shiyong
    Sun, Xianchao
    Zhang, Jiaxin
    Zhang, Bihui
    Chen, Yilai
    Che, Jianping
    Ma, Weiguo
    Ye, Lin
    FRONTIERS IN GENETICS, 2022, 13
  • [28] Exploring the crosstalk of immune cells: The impact of dysregulated RUNX family genes in kidney renal clear cell carcinoma
    Jiang, Zhiwei
    Jiang, Chao
    Teng, Xiangyu
    Hou, Yidong
    Dai, Shuxin
    Liu, Chang
    Tuo, Zhouting
    Bi, Liangkuan
    Yang, Chao
    Wang, Jinyou
    HELIYON, 2024, 10 (09)
  • [29] Potential Application of Pyroptosis in Kidney Renal Clear Cell Carcinoma Immunotherapy and Targeted Therapy
    Qi, Xiaochen
    Che, Xiangyu
    Li, Quanlin
    Wang, Qifei
    Wu, Guangzhen
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [30] The LncRNA signature associated with cuproptosis as a novel biomarker of prognosis in immunotherapy and drug screening for clear cell renal cell carcinoma
    Zhang, Lishuo
    Di, Longjiang
    Liu, Jinhui
    Lei, Xianli
    Gu, Maoli
    Zhang, Wenjing
    Wang, Yufu
    FRONTIERS IN GENETICS, 2023, 14